Fletcher CDM, Bridge JA, Hogendoorn PCW. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press; 2013.

Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.

Article  PubMed  Google Scholar 

Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. World Health Organization classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.

Google Scholar 

Fletcher CD. The evolving classification of soft tissue tumours–an update based on the new 2013 WHO classification. Histopathology. 2014;64(1):2–11.

Article  PubMed  Google Scholar 

Enzinger FM, Winslow DJ. Liposarcoma. Virchows Archiv. 1962;335(4):367–88.

Article  CAS  Google Scholar 

Manji GA, Schwartz GK. Managing liposarcomas: cutting through the fat. J Oncol Pract. 2016;12(3):221–7.

Article  PubMed  Google Scholar 

Rudzinski E, Mawn L, Kuttesch J, Wushensky C, Wills M. Orbital pleomorphic liposarcoma in an eight-year-old boy. Pediatr Dev Pathol. 2011;14(4):339–44.

Article  PubMed  Google Scholar 

Ghadimi MP, Liu P, Peng T, Bolshakov S, Young ED, Torres KE, et al. Pleomorphic liposarcoma: clinical observations and molecular variables. Cancer. 2011;117(23):5359–69.

Article  CAS  PubMed  Google Scholar 

Gebhard S, Coindre JM, Michels JJ, Terrier P, Bertrand G, Trassard M, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26(5):601–16.

Article  PubMed  Google Scholar 

Tandon B, Hagemann IS, Maluf HM, Pfeifer JD, Al-Kateb H. Association of Li-Fraumeni syndrome with small cell carcinoma of the ovary, hypercalcemic type and concurrent pleomorphic liposarcoma of the cervix. Int J Gynecol Pathol. 2017;36(6):593–9.

Article  PubMed  Google Scholar 

Italiano A, Garbay D, Cioffi A, Maki RG, Bui B. Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy. Ann Oncol. 2012;23(8):2205–6.

Article  CAS  PubMed  Google Scholar 

Toulmonde M, Italiano A, Penel N, Cioffi A, Le Cesne A, Isambert N, et al. Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival. J Clin Oncol. 2011;29(15_suppl):10071–10071.

Article  Google Scholar 

• Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(11):1348–65. Most recent recommendations for the management of soft tissue sarcomas.

Article  CAS  PubMed  Google Scholar 

Casali PG, Bruzzi P, Bogaerts J, Blay JY, Panel RCE (RCE) C. Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper. Ann Oncol. 2014;26(2):300–6.

Article  PubMed  PubMed Central  Google Scholar 

Frezza AM, Jones RL, Vullo SL, Asano N, Lucibello F, Ben-Ami E, et al. Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: a multi-institutional case series. JAMA Oncol. 2018;4(9):e180219–e180219.

Article  PubMed  PubMed Central  Google Scholar 

Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, et al. Systemic treatments in MDM2 positive intimal sarcoma: a multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Cancer. 2020;126(1):98–104.

Article  CAS  PubMed  Google Scholar 

• Smrke A, Frezza AM, Giani C, Somaiah N, Brahmi M, Czarnecka AM, et al. Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network. ESMO open. 2022;7(3): 100522. International multicentric retrospective data on one of the most rare STS histotypes, clear cell sarcoma, assessing the role of current systemic therapies.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hornick JL. Subclassification of pleomorphic sarcomas: how and why should we care? Ann Diagn Pathol. 2018;37:118–24.

Article  PubMed  Google Scholar 

Miettinen M, Enzinger FM. Epithelioid variant of pleomorphic liposarcoma: a study of 12 cases of a distinctive variant of high-grade liposarcoma. Mod Pathol. 1999;12(7):722–8.

CAS  PubMed  Google Scholar 

Anderson WJ, Jo VY. Pleomorphic liposarcoma: updates and current differential diagnosis. Seminars in diagnostic pathology. WB Saunders; 2019;36(2).

Creytens D, Folpe AL, Koelsche C, Mentzel T, Ferdinande L, van Gorp JM, et al. Myxoid pleomorphic liposarcoma—a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma. Mod Pathol. 2021;34(11):2043–9.

Article  CAS  PubMed  Google Scholar 

Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet août. 2010;42(8):715–21.

Article  CAS  Google Scholar 

Idbaih A, Coindre JM, Derré J, Mariani O, Terrier P, Ranchère D, et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest. 2005;85(2):176–81.

Article  CAS  PubMed  Google Scholar 

Sugita S, Seki K, Yokozawa K, Tochigi N, Furuta K, Hisaoka M, et al. Analysis of CHOP rearrangement in pleomorphic liposarcomas using fluorescence in situ hybridization. Cancer Sci. 2009;100(1):82–7.

Article  CAS  PubMed  Google Scholar 

Lee JC, Jeng YM, Liau JY, Tsai JH, Hsu HH, Yang CY. Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas. Mod Pathol. 2015;28(8):1064–73.

Article  CAS  PubMed  Google Scholar 

Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Cancer Cytopathol. 2014;122(2):128–37.

Article  PubMed  Google Scholar 

Åberg E, Saccoccia F, Grabherr M, Ore WYJ, Jemth P, Hultqvist G. Evolution of the p53-MDM2 pathway. BMC Evol Biol [Internet]. 2017 [cité 10 oct 2020];17(1). Disponible sur: http://bmcevolbiol.biomedcentral.com/articles/10.1186/s12862-017-1023-y.

Ciliberti V, Cretella P, Zeppa P, Caputo A. Pleomorphic liposarcoma with liver metastasis diagnosed by combined fine-needle aspiration cytology and core-needle biopsy. Diagn Cytopathol. 2022;50(1):E28-31.

Article  PubMed  Google Scholar 

Apostolou G, Biteli M, Chatzipantelis P. Cytopathological diagnosis of metastatic pleomorphic liposarcoma in the lung: a report of a case correlated with the histopathology of the primary tumour. Diagn Cytopathol. 2009;37(9):667–70.

Article  PubMed  Google Scholar 

Dodd LG, Jiang X, Rao K, Bui MM. Pleomorphic liposarcoma: a cytologic study of five cases. Diagn Cytopathol. 2015;43(2):138–43.

Article  PubMed  Google Scholar 

Wakely PE Jr, Wangsiricharoen S, Ali SZ. Pleomorphic liposarcoma: a clinicopathologic study of 20 FNA cases. Cancer Cytopathol. 2022;130:705–13.

Article  PubMed  Google Scholar 

May CD, Garnett J, Ma X, Landers SM, Ingram DR, Demicco EG, et al. AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC Cancer. 2015;15(1):1–12.

Article  Google Scholar 

Valenciaga A, Iwenofu OH, Tinoco G. Larotrectinib in a patient with advanced pleomorphic liposarcoma of the uterus. J Natl Compr Canc Netw. 2021;19(7):775–9.

Article  CAS  PubMed  Google Scholar 

Friedman JL, Bistritz JI, Robinson MJ. Pleomorphic liposarcoma of the pterygomandibular space involving the maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 1995;79(4):488–91.

Article  CAS  Google Scholar 

Agarwal J, Kadakia S, Agaimy A, Ogadzanov A, Khorsandi A, Chai RL. Pleomorphic liposarcoma of the head and neck: presentation of two cases and literature review. Am J Otolaryngol. 2017;38(4):505–7.

Article  PubMed  Google Scholar 

Wang JG, Wei ZM, Liu H, Li YJ. Primary pleomorphic liposarcoma of pericardium. Interact Cardiovasc Thorac Surg. 2010;11(3):325–7.

Article  PubMed  Google Scholar 

Tan NY, Najam M, Lyle MA, Maleszewski JJ, Collins JD, Klarich KW. Dramatic presentation of cardiac pleomorphic liposarcoma. Circulation: Cardiovasc Imaging. 2021;14(8):e012620.

Google Scholar 

Ganesan S, Moorthy N, Venkataraman SK, Mahipathy SRRV, Sundaramurthy N. Giant pleomorphic liposarcoma of anterior chest wall. JK Sci J Med Educ Res. 2022;24(2):140–2.

Google Scholar 

Kim MJ, Koo HL, Jun SY, Ro JY. Pleomorphic liposarcoma of the kidney: a case report. Kor J Pathol. 2003;37(3):210–3.

Google Scholar 

Dey T, Khosla D, Kumar D, Chatterjee D, Madan R, Singh H, et al. Rare case of primary pulmonary pleomorphic liposarcoma treated with multimodal therapy. Ochsner J. 2021;21(4):431–5.

Article  PubMed  PubMed Central  Google Scholar 

Verdugo D, Voltaggio L, Hoot A, Rodriguez FJ. Cerebral pleomorphic liposarcoma: clinicopathologic findings. Clin Neuropathol. 2019;38(5):233.

Article  PubMed  Google Scholar 

Tiemeier GL, Brown JM, Pratap SE, McCarthy C, Kastrenopoulou A, Bradley K, et al. Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour. Clin Sarcoma Res. 2018;8(1):1–9.

Article  Google Scholar 

Torigoe T, Matsumoto T, Terakado A, Takase M, Yamasaki S, Kurosawa H. Primary pleomorphic liposarcoma of bone: MRI findings and review of the literature. Skelet Radiol. 2006;35(7):536–8.

Article